Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
Explore this paper's citation graph
Summary
Levels of endogenous sex hormones are strongly associated with breast cancer risk in postmenopausal women, and SHBG was associated with a decrease in Breast cancer risk.
- Type
- review
- Published
- 2002-04-17
- Cited by
- 1,857
- References
- 26
- Access
- Open access
- OpenAlex
- https://openalex.org/W1511930757
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8289143
Keywords
Estrone, Sex hormone-binding globulin, Breast cancer, Dehydroepiandrosterone sulfate, Estrone sulfate
References
- Dehydroepiandrosterone sulfate and breast cancer risk.
- Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
- Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
- Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
- Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.
- A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
- Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer
- Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan.
- Tamoxifen in the Prevention of Breast Cancer
- The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.
- Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
- Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
- Serum sex hormone levels after menopause and subsequent breast cancer.
- Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.
- A prospective study of estradiol and breast cancer in Japanese women.
- Sex hormone levels in serum in relation to the development of breast cancer.
- The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
- A prospective study of endogenous hormones and breast cancer.
- Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Cited by
- Serum levels of sex hormones and breast cancer risk in premenopausal women: a case–control study (USA)
- Job stress and breast cancer risk: the nurses' health study.
- Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
- Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence
- Effects of Raloxifene on Circulating Prolactin and Estradiol Levels in Premenopausal Women at High Risk for Developing Breast Cancer
- Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis
- Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women
- Testosterone addition during menopausal hormone therapy: effects on mammographic breast density
- Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer
- Design of the sex hormones and physical exercise (SHAPE) study
- Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence
- Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case–control study in Chongqing, China
- Lifetime Reproductive and Anthropometric Risk Factors for Breast Cancer in Postmenopausal Women
- Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
- The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
- Educational Differences in Postmenopausal Breast Cancer – Quantifying Indirect Effects through Health Behaviors, Body Mass Index and Reproductive Patterns
- Prospective Association between Dietary Fiber Intake and Breast Cancer Risk
- Association between Cutaneous Nevi and Breast Cancer in the Nurses' Health Study: A Prospective Cohort Study
- n-3 Polyunsaturated Fatty Acids and Mechanisms to Mitigate Inflammatory Paracrine Signaling in Obesity-Associated Breast Cancer
- Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.
Related papers
- Estrone sulfate stimulates growth of nitrosomethylurea‐induced breast carcinoma in vivo in the rat
- Changes in plasma levels of estrone sulfate and estrone in the pregnant ewe around parturition.
- Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer.
- The metabolism of estrone sulfate in the female rhesus monkey.
- Plasma estrone sulfate levels in postmenopausal women.
- Comparative fate of estrone and estrone sulfate in man.
- Involvement of Estrone-3-Sulfate Transporters in Proliferation of Hormone-Dependent Breast Cancer Cells
- Estrone sulfate, estrone and estradiol concentrations in normal and cirrhotic postmenopausal women.
- Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue.
- Relationship between the level of estrone sulfate in the plasma and the number of fetuses during pregnancy in the gilt.